FCA
COGT icon

FinTrust Capital Advisors’s Cogent Biosciences COGT Stock Holding History

FinTrust Capital Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed – – 1225
2022
Q1 		$0 Hold
50
– – ﹤0.01% 1228
2021
Q4 		$0 Buy
+50
New +$435 ﹤0.01% 1198

Other funds holding COGT

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FinTrust Capital Advisors's COGT Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of Cogent Biosciences (COGT) in Q2 2022, closing a stake of 50 shares.

FinTrust Capital Advisors first reported a position in COGT in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 112 funds tracked by Wall St. Rank hold COGT as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining Cogent Biosciences position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 50 Cogent Biosciences shares in Q2 2022.
  • FinTrust Capital Advisors first reported a position in Cogent Biosciences in Q4 2021 and held it in 2 quarters.
  • FinTrust Capital Advisors's Cogent Biosciences position peaked at $0 in Q1 2022.
  • 112 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.